Related Experiment Videos
Thigh muscle mass and function in patients treated with glucocorticoids
European Journal of Clinical Investigation
|December 1, 1985
Summary
Glucocorticoid medications can cause muscle loss. Moderate physical training in patients using prednisone demonstrated improvements in muscle mass, strength, and function, reversing this wasting effect.
Area of Science:
- Endocrinology
- Sports Medicine
- Rehabilitation Science
Background:
- Glucocorticoid therapy is associated with proximal skeletal muscle wasting.
- Previous studies in rats suggest physical training may mitigate muscle loss.
- The efficacy of physical training in reversing glucocorticoid-induced muscle wasting in humans remains unestablished.
Purpose of the Study:
- To investigate the effects of moderate physical training on muscle mass and function in human patients treated with glucocorticoids.
- To quantitatively assess changes using computed tomography (CT) and isokinetic dynamometry.
- To determine if physical training can reverse glucocorticoid-induced muscle wasting.
Main Methods:
- Quantitative assessment of mid-thigh muscle area and fat/muscle ratio using computed tomography (CT).
- Measurement of thigh muscle strength and endurance using an isokinetic dynamometer (Cybex II).
- A 50-day isokinetic training program was implemented in a subset of patients.
Main Results:
- Prednisone-treated patients exhibited significantly reduced mid-thigh muscle area (20-45%) and increased fat/muscle ratio (25-100%) compared to controls.
- Thigh muscle strength and work output were reduced by 20-30% in patients on prednisone.
- Fifty days of isokinetic training led to increased muscle area, decreased fat area, and normalized strength and endurance.
Conclusions:
- Glucocorticoid-induced muscle wasting is a significant concern in patients.
- Moderate physical training, specifically isokinetic training, can effectively reverse muscle wasting and functional deficits.
- Increasing physical activity represents a viable strategy to counteract the catabolic effects of glucocorticoids on skeletal muscle.